Ictus Le sequele epilettiche Gaetano Zaccara U.O. Neurologia, ASF Firenze Firenze, 8 novembre 2014.
-
Upload
giacobbe-lazzari -
Category
Documents
-
view
215 -
download
1
Transcript of Ictus Le sequele epilettiche Gaetano Zaccara U.O. Neurologia, ASF Firenze Firenze, 8 novembre 2014.
IctusLe sequele epilettiche
Gaetano ZaccaraU.O. Neurologia, ASF Firenze
Firenze, 8 novembre 2014
Stroke emorragico: crisi immediate
F, 64 aa
Neurologìa ASF
TEA carot. Sn: 19 settembre 2007
Stroke: 24 settembre 2007Crisi: 24 settembre 2007
Mioclonìe emisoma Dx
Crisi immediate
• Si verificano generalmente all’esordio di una emorragia cerebrale
• Costituiscono il segno iniziale di uno stroke nel 4.8% dei casi
• Sono generalmente isolate e parziali• Le crisi elettrografiche sono 4 volte più
frequenti delle crisi cliniche
Stroke emorragico: crisi precoci
mioclonìe emivolto Dx fine crisi
F, 80 aa
Stroke : 14 settembre 2007Inizio crisi : 17 settembre 2007
EEG : 17 settembre 2007
Neurologìa ASF
Neurologìa ASF
Crisi sintomatiche acute
• Le crisi sintomatiche acute si osservano entro la prima settimana di un insulto cerebrale e non sono considerate espressione di epilessia.
• L’incidenza cumulativa delle crisi sintomatiche acute fino alla età di 80 anni di età è: 3.7%
• Queste crisi sono associate ad un aumento del rischio che dal danno neurologico possa originare una epilessia (Annegers et al., 1995)
Quali conseguenze hanno le crisi precoci nel paziente affetto da patologia
vascolare?
• Studi condotti sull’animale: aumento dell’area infartuale
• Tra i pazienti con ICH un maggiore deterioramento neurologico è stato osservato nei pazienti con crisi precoci (Vespa et al., 2003)
• Aumento della mortalità (Vernino et al 2003)
Crisi tardive
• Sono quelle crisi che insorgono dopo almeno 15 giorni dall’evento vascolare
• Si associano ad un maggior rischio di epilessia anzi ne costituiscono l’esordio
• Determinate da alterazioni strutturali della corteccia cerebrale (gliosi, cicatrice meningocerebrale, deafferentazione, perdita selettiva di neuroni, sprouting neuronale)
Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against
Epilepsy (ILAE) and the International Bureau for Epilepsy
Epilepsy is a disorder of the brain characterised by an enduring predisposition to generate epileptic seizures and by the neurobiologic, cognitive, psychological, and social consequences of this condition. The definition of epilepsy requires the occurrence of at least one epileptic seizure.
Fisher et al., Epilepsia 46:470-472, 2005
I dati epidemiologici
Neurology. 2011 Nov 15;77(20):1785-93.
Fattori di rischio delle crisi sintomatiche acute
• Emboli cardiogeni
• Lesioni molto estese • Interessamento della corteccia• Emorragia causata da trombosi delle
vene cerebrali
• Emorragia subaracnoidea • Sindrome da riperfusione • Ipoperfusione globale
Three thousand three-hundred ten patients with no history of epilepsy who presented with first stroke between 1995 and 2007. Mean follow-up: 3.8 yearsPSE incidence at 3 months and 1, 5, and 10 years were estimated at 1.5%, 3.5%, 9.0%, and 12.4%, respectively
Three thousand three-hundred ten patients with no history of epilepsy who presented with first stroke between 1995 and 2007
Terapia farmacologicaLa profilassi ed il trattamento delle
crisi sintomatiche acute
Seizures (epileptic attacks) after stroke are a major clinical problem. It is unclear whether antiepileptic drugs are effective in preventing seizures after stroke. This Cochrane review did not find any high quality clinical trials that have assessed whether antiepileptic drugs are more effective than placebo in preventing seizures after stroke. Currently, there is not enough evidence to justify the routine use of antiepileptic drugs to prevent seizures after stroke. Further research is needed for this important clinical problem.
Cochrane Database Syst Rev. 2014 Jan 24;1:CD005398
Sykes L, Wood E, Kwan J.
The prophylactic use of an antiepileptic drug in intracerebral hemorrhage
Results—157 patients met criteria for review. 46 (29%) patients were placed on a prophylactic AED. Eleven percent of patients placed on a prophylactic AED had an early seizure versus 6.3% who was not placed on a prophylactic AED. Interpretations— Patients with acute, spontaneous ICH are at an increased risk for early seizures. AED use is not significantly associated with the risk of early seizures, long-term epilepsy, disability, or death.
Objective— To evaluate whether patients presenting with acute, spontaneous intracerebral hemorrhage (ICH) benefit from prescription of prophylactic antiepileptic drugs (AEDs).
Redding et al., Clin Neurol Neurosurg. 2011 December ; 113(10): 895–897.
Seizures After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review of Outcomes
Incidence of early seizure amongpatients treated for aneurysmal subarachnoid hemorrhage, by cohort.
Incidence of late seizure amongpatients treated for aneurysmal subarachnoid hemorrhage, by cohort.
Rapert et al., 2012 WORLD NEUROSURGERY
Twenty-five studies involving 7002 patients
Chumnanvej et al., Neurosurgery. 2007 60(1):99-102
Retrospective chart review on 269 patients , 85 of whom received prophylactic levetiracetam (n= 25) or phenytoin (n= 60). Glasgow Coma Scores at dismissal (median, 14 vs. 11, P = 0.023), and lower seizure incidence (0.0 vs. 8%, P = 0.03) was observed for patients receiving levetiracetam than for those treated withphenytoin. Also a trend was observed for a greater cognitive function retention rate (56.7% vs. 36%, P = 0.08) in patients treated with Levetiracetam.
LEV
PHT
Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role
of antiepileptics.• METHODS: Multicenter, prospective, observational study. Analysis of risk factors
for seizures experienced before the diagnosis of CVT (presenting seizures) or within the following 2 weeks (early seizures).
• RESULTS: Two hundred forty-five of 624 (39.3%) patients with CVT experienced presenting seizures, and 43 (6.9%) patients had early seizure. In logistic-regression analysis, supratentorial lesion (OR=3.09, 95% CI=1.56 to 9.62) and presenting seizures (OR=1.74, 95% CI=0.90 to 3.37) predicted early seizures. The risk of early seizures in patients with supratentorial lesions and presenting seizures was significantly lower when AED prophylaxis was used (1 with seizures in 148 patients with AEDs vs 25 in 47 patients without AEDs; OR=0.006, 95% CI=0.001 to 0.05).
• CONCLUSIONS: Our results support the prescription of AEDs in acute CVT patients with supratentorial lesions who present with seizures.
Ferro et al., Stroke. 2008 Apr;39(4):1152-8.
Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis.
Price M, Günther A, Kwan JS Cochrane Database Syst Rev. 2014 Aug 2;8:CD005501.
MAIN RESULTS: No relevant studies were found.AUTHORS' CONCLUSIONS: There is no evidence to support or refute the use of antiepileptic drugs for the primary or secondary prevention of seizures related to intracranial venous thrombosis. Well-designed randomised controlled trials are urgently needed to inform practice.
Terapia farmacologicaIl trattamento dopo una prima crisi
sintomatica remota
Single Seizure - History
Evolution in thinking• Gowers (1881) - “seizures
beget seizures”• Current evidence:
– 60% of 1st seizures do not recur
– Delayed treatment does not influence outcome
Which information from RCTs?
Rowan et al Neurology 64: 1868-1873, 2005
Saetre et al., Epilepsia, 48:1292–1302, 2007
Brodie et al., Epilepsy Res. 37, 81–87, 1999
Retention analysis in studies performed in elderly patients with newly diagnosed epilepsies
Reduced plasma nisoldipine concentrations in phenytoin-treated patients with epilepsy.
Michelucci et al., 1996
Plasma nisoldipine concentration after a single oral dose of a controlled-release formulation of nisoldipine in 12 healthy controls and in 12 patients under treatment with phenytoin.
Nisoldipine dose was 40 mg in patients and 20 mg in controls.
We do not have a single drug for all clinical conditions
Comorbidity Suggested drugPatients with vascular diseases
lamotrigine, gabapentin, levetiracetam, zonisamide
Dementia with depression or apathy
Lamotrigine
Dementia with aggression valproate, gabapentin, oxcarbazepine
Brain tumor levetiracetam, valproate, topiramate, zonisamide
Substance abuse topiramateMigraine valproate, topiramate
Grazie per l’attenzione